A comprehensive view of Hospital/Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Kaiser Health News reports government-funded courses of Pfizer’s Paxlovid antiviral expected to run out in a few months, cutting access to the treatment to the uninsured and seniors; about 6 million people have take Paxlovid in US

AstraZeneca: Enhertu achieved statistically significant overall survival, reducing the risk of death by 36% vs. trastuzumab emtansine T-DM1 in patients with HER2-positive metastatic breast cancer in DESTINY-Breast03 trial

AstraZeneca presenting 12 breast cancer medicines and potential new treatments at 2022 San Antonio Breast Cancer Symposium; AZ to make 55 presentations including two presentations demonstrating effectiveness of Enhertu trastuzumab deruxtecan

US consumers give healthcare system a ranking of 4.98 out of 10, with 45.4% of respondents reporting they do not trust pharmaceutical firms; 66% reported drug diversion at a hospital would negatively affect their perception of the hospital: Bluesight

Cardinal Health reports fiscal 2023 Q1 earning attributable to Cardinal down at US$110.0M from US$271.0M a year ago, revenue up 13% year-over-year to US$49.6M; results due to drop in Medical profit partially offset by increase in Pharmaceutical profit

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count